1. Developing a Screening Strategy to Identify Hepatotoxicity and Drug Interaction Potential of Botanicals.
- Author
-
Roe, Amy L., Krzykwa, Julie, Calderón, Angela I., Bascoul, Cécile, Gurley, Bill J., Koturbash, Igor, Li, Albert P., Liu, Yitong, Mitchell, Constance A., Oketch-Rabah, Hellen, Si, Lin, van Breemen, Richard B., Walker, Heather, and Ferguson, Stephen S.
- Subjects
- *
DRUG side effects , *SMALL molecules , *DRUG interactions , *CONSORTIA , *HEPATOTOXICOLOGY - Abstract
AbstractBotanical supplements, herbal remedies, and plant-derived products are used globally. However, botanical dietary supplements are rarely subjected to robust safety testing unless there are adverse reports in post-market surveillance. Botanicals are complex and difficult to assess using current frameworks designed for single constituent substances (e.g. small molecules or discrete chemicals), making safety assessments costly and time-consuming. The liver is a primary organ of concern for potential botanical-induced hepatotoxicity and botanical-drug interactions as it plays a crucial role in xenobiotic metabolism. The NIH-funded Drug Induced Liver Injury Network noted that the number of botanical-induced liver injuries in 2017 nearly tripled from those observed in 2004–2005. New approach methodologies (NAMs) can aid in the rapid and cost-effective assessment of botanical supplements for potential hepatotoxicity. The Hepatotoxicity Working Group within the Botanical Safety Consortium is working to develop a screening strategy that can help reliably identify potential hepatotoxic botanicals and inform mechanisms of toxicity. This manuscript outlines the Hepatotoxicity Working Group’s strategy and describes the assays selected and the rationale for the selection of botanicals used in case studies. The selected NAMs evaluated as a part of this effort are intended to be incorporated into a larger battery of assays to evaluate multiple endpoints related to botanical safety. This work will contribute to a botanical safety toolkit, providing researchers with tools to better understand hepatotoxicity associated with botanicals, prioritize and plan future testing as needed, and gain a deeper insight into the botanicals being tested. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF